|
KIAA1671 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.38679999997604E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.562720E-04 |
| Normal-vs-Stage2 |
1.540170E-02 |
| Normal-vs-Stage3 |
1.53213999999346E-05 |
| Normal-vs-Stage4 |
1.00990005247326E-09 |
| Stage1-vs-Stage2 |
8.048400E-01 |
| Stage1-vs-Stage3 |
1.544800E-01 |
| Stage1-vs-Stage4 |
1.606270E-04 |
| Stage2-vs-Stage3 |
2.289600E-01 |
| Stage2-vs-Stage4 |
5.222100E-03 |
| Stage3-vs-Stage4 |
3.580300E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.53323999999566E-05 |
| Normal-vs-AfricanAmerican |
7.192900E-04 |
| Normal-vs-Asian |
1.131860E-02 |
| Caucasian-vs-AfricanAmerican |
5.007400E-01 |
| Caucasian-vs-Asian |
8.310400E-01 |
| AfricanAmerican-vs-Asian |
5.263600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.159500E-04 |
| Normal-vs-Female |
2.36750000004449E-06 |
| Male-vs-Female |
6.703800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.989300E-04 |
| Normal-vs-Age(41-60Yrs) |
3.65130000000713E-05 |
| Normal-vs-Age(61-80Yrs) |
4.35260000042348E-07 |
| Normal-vs-Age(81-100Yrs) |
7.987000E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.986600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.895900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.681170E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.289600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.632800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.600200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.21369999999976E-05 |
| Classical-VS-Follicular |
3.525700E-02 |
| Classical-VS-Other |
6.321800E-01 |
| Classical-VS-Normal |
3.804300E-04 |
| Tall-VS-Follicular |
3.223800E-02 |
| Tall-VS-Other |
4.805800E-01 |
| Tall-VS-Normal |
1.54299995003271E-09 |
| Follicular-VS-Other |
9.135000E-01 |
| Follicular-VS-Normal |
1.04349999996423E-06 |
| Other-VS-Normal |
4.802500E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.68707999999018E-05 |
| Normal-vs-N1 |
1.384820E-03 |
| N0-vs-N1 |
5.861400E-01 |
|
|
